BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 22419173)

  • 1. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
    Pan G; Wang T; Yao H; Pei D
    Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in cell lineage reprogramming.
    Zhou J; Yue W; Pei X
    Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
    Anastasia L; Pelissero G; Venerando B; Tettamanti G
    Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprogramming of somatic cells.
    Rajasingh J
    Prog Mol Biol Transl Sci; 2012; 111():51-82. PubMed ID: 22917226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere rejuvenation during nuclear reprogramming.
    Marión RM; Blasco MA
    Curr Opin Genet Dev; 2010 Apr; 20(2):190-6. PubMed ID: 20176474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cells: an emerging theranostics platform.
    Nelson TJ; Terzic A
    Clin Pharmacol Ther; 2011 May; 89(5):648-50. PubMed ID: 21512525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
    Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
    Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic cloning and somatic cell reprogramming: every road leads to Rome].
    Yang J; Liu GQ; Hong TP
    Sheng Li Ke Xue Jin Zhan; 2009 Apr; 40(2):101-5. PubMed ID: 19558136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iPS cell technology in regenerative medicine.
    Lengner CJ
    Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic manipulation and studying of differentiation properties of rat induced pluripotent stem cells].
    Liskovykh MA; Chuĭkin IA; Ranjan A; Popova E; Tolkunova EN; Chechik LL; Malinin AIu; Morozova AV; Mosienko V; Bader M; alenina N; Tomilin AN
    Tsitologiia; 2011; 53(12):946-51. PubMed ID: 22359953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical strategies for stem cell biology and regenerative medicine.
    Zhu S; Wei W; Ding S
    Annu Rev Biomed Eng; 2011 Aug; 13():73-90. PubMed ID: 21513460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.
    Li Y; Geng YJ
    Growth Horm IGF Res; 2010 Dec; 20(6):391-8. PubMed ID: 20956084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
    de Lázaro I; Yilmazer A; Kostarelos K
    J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-mediated somatic cell reprogramming.
    Kuo CH; Ying SY
    J Cell Biochem; 2013 Feb; 114(2):275-81. PubMed ID: 22961769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming adult hematopoietic cells.
    Kaneko S; Otsu M; Nakauchi H
    Curr Opin Hematol; 2010 Jul; 17(4):271-5. PubMed ID: 20571391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of mass spectrometry-based proteomics in the study of cellular reprogramming and induced pluripotent stem cells.
    Benevento M; Munoz J
    Expert Rev Proteomics; 2012 Aug; 9(4):379-99. PubMed ID: 22967076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
    Romano G
    Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can controlled cellular reprogramming be achieved using microRNAs?
    Sun X; Fu X; Han W; Zhao Y; Liu H
    Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concise review: non-cell autonomous reprogramming: a nucleic acid-free approach to induction of pluripotency.
    Parameswaran S; Balasubramanian S; Rao MS; Ahmad I
    Stem Cells; 2011 Jul; 29(7):1013-20. PubMed ID: 21544901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.